RPCEC00000275Completed未知
Results of antimicrobial stewardship program in a tertiary care hospital: ambispective cohort study - PROGEAN-FARM
Pharmaceutical Promotion and Prevention Research Group0 sites514 target enrollmentStarted: May 30, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 514
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 years to one (—)
- Sex
- All
Inclusion Criteria
- •1. Patient older than 18 years.
- •2. Patients who, within their pharmacotherapy, have a minimum prescribed one of the following antibiotics:
- •Penicillins: Piperacillin / Tazobactam.
- •Cephalosporins: Ceftriaxone, Ceftazidime, Cefepime, Ceftaroline.
- •Carbapenems: Meropenem, Doripenem, Imipenem / Cilastatin, Ertapenem.
- •Quinolones: Ciprofloxacin.
- •Glycopeptides: Vancomycin.
- •Polymyxins: Polymyxin B, Colistin
- •Oxazolidinones: Linezolid.
- •Cyclic lipopeptides: Daptomycin.
- •Tetracyclines: Tigecycline.
Exclusion Criteria
- •1. Patients without the first evaluation by the treating medical specialty.
- •2. Patients receiving extracorporeal membrane oxygenation (ECMO).
- •3. Patients with cystic fibrosis. and. Administration of antimicrobials subcutaneously, intraperitoneally or intrathecally.
- •4. Patients admitted to surgery and hemodynamics.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
The impact of an antimicrobial stewardship team on the appropriateness of antimicrobialtherapy in sepsisSepsisACTRN12618000116224Alfred Hospital Pharmacy Department120
Completed
Not Applicable
Antibiotic prescribing in an English secondary care setting before and during the COVID-19 pandemicISRCTN14825813niversity of Hertfordshire880
Not yet recruiting
Not Applicable
Study to rationalize antibiotic usage in NICCTRI/2021/05/033353KASTURBA MEDICAL COLLEGE MANIPA
Completed
Not Applicable
Exploratory study on the effects of antimicrobial therapy for refractory uveitis due to sarcoidosis.SarcoidosisJPRN-UMIN000018247Tokyo medical and dental university10
Completed
Not Applicable
Study of efficiency of Gana dhoop as fumigating agent in comparison with formaliCTRI/2022/11/047603KIRAN KULKARNI